| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 0.15 | (4.95) | (2.59)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 0.66 | (7.80) | (3.67)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 2.17 | (5.29) | (2.24)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 4.17 | (4.76) | (2.26)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 8.19 | (8.74) | (2.60)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Monthly Valuation Update and Factsheet | 13-Feb-2026 | 07:00 | RNS |
| Corxel completes $287 million Series D-1 financing | 23-Jan-2026 | 07:00 | RNS |
| Director/PDMR Shareholding | 22-Jan-2026 | 10:00 | RNS |
| RTW Biotech portfolio co Aktis Oncology raises $... | 12-Jan-2026 | ShareCast |
| Total Voting Rights | 02-Jan-2026 | ShareCast |
No deals were found in the last 28 days.
| Currency | US Dollars |
| Share Price | $ 2.07 |
| Change Today | $ -0.04 |
| % Change | -1.90 % |
| 52 Week High | $2.3 |
| 52 Week Low | $1.1 |
| Volume | 282,177 |
| Shares Issued | 326.37m |
| Market Cap | $675.59m |
| Beta | 0.38 |
| RiskGrade | 206 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:47 | 3,481 @ $2.08 |
| 15:01 | 4,616 @ $2.07 |
| 14:21 | 3 @ $2.07 |
| 13:31 | 11,234 @ $2.08 |
| 12:47 | 4,500 @ $2.08 |
| Chair | William (Bill) Simpson |
You are here: research